Zobrazeno 1 - 10
of 634
pro vyhledávání: '"LYME disease vaccines"'
Autor:
Ghadge SK; Valneva Austria, Vienna, Austria., Schneider M; Valneva Austria, Vienna, Austria., Dubischar K; Valneva Austria, Vienna, Austria., Wagner L; Valneva Austria, Vienna, Austria., Kadlecek V; Valneva Austria, Vienna, Austria., Obersriebnig M; Valneva Austria, Vienna, Austria., Hochreiter R; Valneva Austria, Vienna, Austria., Klingler A; Assign Data Management and Biostatistics, Innsbruck, Austria., Larcher-Senn J; Assign Data Management and Biostatistics, Innsbruck, Austria., Derhaschnig U; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Bender W; Valneva Austria, Vienna, Austria., Eder-Lingelbach S; Valneva Austria, Vienna, Austria. Electronic address: susanne.eder-lingelbach@valneva.com., Bézay N; Valneva Austria, Vienna, Austria.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Nov; Vol. 24 (11), pp. 1275-1286. Date of Electronic Publication: 2024 Jul 16.
Autor:
Bézay N; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Wagner L; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Kadlecek V; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Obersriebnig M; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Wressnigg N; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Hochreiter R; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Schneider M; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Dubischar K; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria., Derhaschnig U; Medical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria., Klingler A; Assign Data Management and Biostatistics, Innsbruck, Austria., Larcher-Senn J; Assign Data Management and Biostatistics, Innsbruck, Austria., Eder-Lingelbach S; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria. Electronic address: susanne.eder-lingelbach@valneva.com., Bender W; Valneva Austria, Campus Vienna Biocenter 3, Vienna, Austria.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. 1045-1058. Date of Electronic Publication: 2024 May 31.
Autor:
Gutierrez MP; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Huckaby AB; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Yang E; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Weaver KL; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Hall JM; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Hudson M; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Dublin SR; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Sen-Kilic E; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Rocuskie-Marker CM; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Miller SJ; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA., Pritchett CL; College of Public Health, East Tennessee State University, Johnson City, TN, USA., Mummadisetti MP; AVM Biomed, Pottstown, PA, USA., Zhang Y; Department of Biology, West Virginia University, Morgantown, WV, USA., Driscoll T; Department of Biology, West Virginia University, Morgantown, WV, USA., Barbier M; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; Vaccine Development Center, West Virginia University, Health Sciences Center, Morgantown, WV, USA. Electronic address: mabarbier@hsc.wvu.edu.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126084. Date of Electronic Publication: 2024 Jun 26.
Autor:
Johnson EE; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Epidemiology and Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA., Hart TM; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Fikrig E; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Aug 14; Vol. 230 (Supplement_1), pp. S82-S86.
Autor:
Dreyfus J; Pfizer, Inc., New York, NY, USA. Electronic address: jill.dreyfus@pfizer.com., Munnangi S; IQVIA, Falls Church, VA, USA., Bengtsson C; IQVIA, Solna, Sweden., Correia B; IQVIA, Oeiras, Portugal., Figueiredo R; IQVIA, Espoo, Finland., Stark JH; Vaccines, Antivirals, and Evidence Generation, Medical Affairs, Pfizer Biopharma Group, Cambridge, MA, USA., Zawora M; Pfizer, Inc., New York, NY, USA., Riddle MS; Pfizer, Inc., New York, NY, USA., Maguire JD; Pfizer, Inc., New York, NY, USA., Jiang Q; Pfizer, Inc., New York, NY, USA., Ianos C; Pfizer AG, Switzerland., Naredo Turrado J; IQVIA, Bordeaux, France., Svanström H; IQVIA, Copenhagen, Denmark., Bailey S; Pfizer, Inc., New York, NY, USA., DeKoven M; IQVIA, Falls Church, VA, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Feb 15; Vol. 42 (5), pp. 1094-1107. Date of Electronic Publication: 2024 Jan 22.
Autor:
O'Bier NS; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA., Camire AC; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA., Patel DT; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA., Billingsley JS; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA., Hodges KR; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA., Marconi RT; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA.
Publikováno v:
MBio [mBio] 2024 Oct 16; Vol. 15 (10), pp. e0215924. Date of Electronic Publication: 2024 Sep 17.
Autor:
Hajdusek O; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Ceske Budejovice 37005, Czech Republic. Electronic address: hajdus@paru.cas.cz., Perner J; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Ceske Budejovice 37005, Czech Republic.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Oct; Vol. 23 (10), pp. 1105-1106. Date of Electronic Publication: 2023 Jul 04.
Autor:
Pfeifle A; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Zhang W; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Cao J; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada., Thulasi Raman SN; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada., Anderson-Duvall R; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Tamming L; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Gravel C; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada., Coatsworth H; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada., Chen W; Human Health Therapeutics Research Center, National Research Council of Canada, Ottawa, Canada., Johnston MJW; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.; Department of Chemistry, Carleton University, Ottawa, Canada., Sauve S; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada., Rosu-Myles M; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada., Wang L; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Li X; Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2024 Dec; Vol. 13 (1), pp. 2399949. Date of Electronic Publication: 2024 Oct 11.
Autor:
Gould LH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, New York, New York, USA., Stark JH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Cambridge, Massachusetts, USA., McFadden B; Behavioralize LLC, Wynnewood, Pennsylvania, USA.; The Department of Agricultural Economics and Agribusiness, University of Arkansas, Fayetteville, Arkansas, USA., Patel N; Behavioralize LLC, Wynnewood, Pennsylvania, USA., Kelly PH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Collegeville, Pennsylvania, USA., Riis J; Behavioralize LLC, Wynnewood, Pennsylvania, USA.
Publikováno v:
Zoonoses and public health [Zoonoses Public Health] 2024 Aug; Vol. 71 (5), pp. 526-537. Date of Electronic Publication: 2024 May 10.
Autor:
Stark JH; Vaccines, Antivirals, and Evidence Generation, Pfizer Biopharma Group, Cambridge, Massachusetts, USA., McFadden B; Behavioralize LLC, Wynnewood, Pennsylvania, USA.; The Department of Agricultural Economics and Agribusiness, University of Arkansas, Fayetteville, Arkansas, USA., Patel N; Behavioralize LLC, Wynnewood, Pennsylvania, USA., Kelly PH; Vaccines, Antivirals, and Evidence Generation, Pfizer Biopharma Group, Collegeville, Pennsylvania, USA., Gould LH; Vaccines, Antivirals, and Evidence Generation, Pfizer Biopharma Group, New York, New York, USA., Riis J; Behavioralize LLC, Wynnewood, Pennsylvania, USA.
Publikováno v:
Zoonoses and public health [Zoonoses Public Health] 2024 Jun; Vol. 71 (4), pp. 349-358. Date of Electronic Publication: 2024 Jan 04.